The Loratadine Market is estimated at US$175.2 million in 2026 and is projected to grow at a CAGR of 2.5% to reach US$213.5 million by 2034.
End uses cover tablets, syrups, orally disintegrating formats, and combination products designed for broad allergy relief across pediatric and adult patient groups. Competitive intensity is high among generic manufacturers, consumer health brands, and pharmacy private labels, with differentiation based on availability, brand trust, formulation convenience, pricing, and channel reach across modern retail, e commerce, and pharmacy networks.
This product will be delivered within 1-3 business days.
Market Overview
The loratadine market includes branded and generic antihistamine formulations used to manage allergy related conditions such as seasonal rhinitis, chronic urticaria, and other histamine mediated symptoms in both retail and healthcare channels. Its value chain spans active ingredient production, formulation development, dosage manufacturing, packaging, regulatory compliance, distribution through pharmacies and retailers, and promotion through consumer healthcare and prescription adjacent pathways.End uses cover tablets, syrups, orally disintegrating formats, and combination products designed for broad allergy relief across pediatric and adult patient groups. Competitive intensity is high among generic manufacturers, consumer health brands, and pharmacy private labels, with differentiation based on availability, brand trust, formulation convenience, pricing, and channel reach across modern retail, e commerce, and pharmacy networks.
Market Segmentation
By Type
- Tablets
- Capsules
- Syrup
- Orally Disintegrating Tablets
- Extended-Release Combinations
By End-User
- Adults
- Pediatrics
- Geriatrics
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Drug Wholesalers
By Formulation
- Single-Ingredient Loratadine
- Loratadine + Pseudoephedrine
- Loratadine + Montelukast
- Loratadine + Phenylephrine
Key Companies Analysed
- Bayer
- Cadila Pharmaceuticals
- Perrigo
- Teva Pharmaceutical Industries
- Dr. Reddy's Laboratories
- Viatris
- Sun Pharmaceutical
- Cipla
- Aurobindo Pharma
- Lupin
- Apotex
- Sandoz
- Amneal Pharmaceuticals
- Zydus Lifesciences
- Torrent Pharmaceuticals
- Strides Pharma Science
- Hetero
- Glenmark Pharmaceuticals
- Macleods Pharmaceuticals
- Intas Pharmaceuticals
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Loratadine Market Overview
3. Loratadine Market Dynamics
4. Loratadine Market Strategic Analysis
5. Global Loratadine Market Size, Share and Forecast, 2025-2034
6. North America Loratadine Market Outlook to 2034
7. Europe Loratadine Market Outlook to 2034
8. Asia-Pacific Loratadine Market Outlook to 2034
9. Middle East and Africa Loratadine Market Outlook to 2034
10. South and Central America Loratadine Market Outlook to 2034
11. Loratadine Market Competitive Landscape
12. Appendix
Companies Mentioned
- Bayer
- Cadila Pharmaceuticals
- Perrigo
- Teva Pharmaceutical Industries
- Dr. Reddy's Laboratories
- Viatris
- Sun Pharmaceutical
- Cipla
- Aurobindo Pharma
- Lupin
- Apotex
- Sandoz
- Amneal Pharmaceuticals
- Zydus Lifesciences
- Torrent Pharmaceuticals
- Strides Pharma Science
- Hetero
- Glenmark Pharmaceuticals
- Macleods Pharmaceuticals
- Intas Pharmaceuticals
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 175.2 Million |
| Forecasted Market Value ( USD | $ 213.5 Million |
| Compound Annual Growth Rate | 2.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
